methotrexate + anti-H1

Methotrexate + anti-H1 is a non-standard combination of two drugs used together, typically in patients who require both immunosuppressive therapy and symptomatic relief from allergic conditions. Methotrexate is a folic acid antagonist that acts as an antimetabolite and immunosuppressant, inhibiting dihydrofolate reductase to block DNA synthesis and cell replication. It is widely used for autoimmune diseases such as rheumatoid arthritis, psoriasis, and certain cancers. Anti-H1 refers to H1-antihistamines (such as diphenhydramine, cetirizine, loratadine), which are small molecule drugs that act as antagonists at the histamine H1 receptor to relieve symptoms of allergy like itching, sneezing, and runny nose. There is no unique brand or fixed-dose product combining these agents; they may be co-prescribed when clinically indicated.